Literature DB >> 9761778

Targeting of gliadin peptides, CD8, alpha/beta-TCR, and gamma/delta-TCR to Golgi complexes and vacuoles within celiac disease enterocytes.

K P Zimmer1, H Naim, P Weber, H J Ellis, P J Ciclitira.   

Abstract

Celiac disease (CD) is characterized by autodestruction of enterocytes after exposure of genetically susceptible individuals to dietary gluten. To define the transport pathways of proteins involved in the celiac immune response, we wished to determine the subcellular compartments of the intestinal mucosa where wheat gliadin peptides colocalize with receptors of T lymphocytes, including alpha/beta-TCR, gamma/delta-TCR, and CD8. Semithin and ultrathin frozen section of jejunal biopsies from CD patients and controls were used to perform immunofluorescence and immunogold labeling as well as in situ hybridization experiments. In patients with active CD, we detected gliadin peptides in vacuoles and Golgi complexes of enterocytes. CD8, alpha/beta-TCR, and gamma/delta-TCR were found in vacuoles and Golgi complexes within these gliadin-containing enterocytes in addition to the surface of intraepithelial and mucosal T lymphocytes. In contrast, we observed that the localization of CD4, CD3, T cell-restricted intracellular antigen (TIA), and leukocyte common antigen (LCA) was restricted to lymphocytes in CD patients. We further detected labeling signals for gliadin peptides, CD8, alpha/beta-TCR, and gamma/delta-TCR at the basal membrane of enterocytes that were interdigitated by extensions of lymphocytes. In situ hybridization experiments revealed that CD8 and gamma/delta-TCR were not expressed by CD enterocytes. We conclude that CD8, alpha/beta-TCR, and gamma/delta-TCR are targeted to Golgi complexes and vacuoles of small intestinal enterocytes in active CD. The observed process may be involved in the pathogenesis of CD enterocytes. We propose a mechanism for the uptake of CD8, alpha/beta-TCR, and gamma/delta-TCR by the basolateral membrane of small intestinal enterocytes.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9761778     DOI: 10.1096/fasebj.12.13.1349

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  6 in total

1.  Growth factor-like activity of gliadin, an alimentary protein: implications for coeliac disease.

Authors:  Maria Vittoria Barone; Anna Gimigliano; Gabriella Castoria; Giovanni Paolella; Francesco Maurano; Franco Paparo; Maria Maglio; Alba Mineo; Erasmo Miele; Merlin Nanayakkara; Riccardo Troncone; Salvatore Auricchio
Journal:  Gut       Date:  2006-08-04       Impact factor: 23.059

Review 2.  Coeliac disease: an update for pathologists.

Authors:  B C Dickson; C J Streutker; R Chetty
Journal:  J Clin Pathol       Date:  2006-10       Impact factor: 3.411

Review 3.  The immune recognition of gluten in coeliac disease.

Authors:  R Ciccocioppo; A Di Sabatino; G R Corazza
Journal:  Clin Exp Immunol       Date:  2005-06       Impact factor: 4.330

4.  Gliadin peptide P31-43 localises to endocytic vesicles and interferes with their maturation.

Authors:  Maria Vittoria Barone; Merlin Nanayakkara; Giovanni Paolella; Mariantonia Maglio; Virginia Vitale; Raffaele Troiano; Maria Teresa Silvia Ribecco; Giuliana Lania; Delia Zanzi; Sara Santagata; Renata Auricchio; Riccardo Troncone; Salvatore Auricchio
Journal:  PLoS One       Date:  2010-08-18       Impact factor: 3.240

5.  Antigen transport and cytoskeletal characteristics of a distinct enterocyte population in inflammatory bowel diseases.

Authors:  Sabine Kersting; Matthias Bruewer; Guido Schuermann; Axel Klotz; Markus Utech; Matthias Hansmerten; Christian F Krieglstein; Norbert Senninger; Joerg-Dieter Schulzke; Hassan Y Naim; Klaus-Peter Zimmer
Journal:  Am J Pathol       Date:  2004-08       Impact factor: 4.307

Review 6.  Endocytosis in enterocytes.

Authors:  Klaus-Peter Zimmer; Jan de Laffolie; Maria Vittoria Barone; Hassan Y Naim
Journal:  Wien Med Wochenschr       Date:  2016-03-18
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.